Feed Preview

Fast Growing

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate Receptor Encephalitis diagram by Mikhail Kalinin, Wikimedia
Mikhail Kalinin, Wikimedia

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Top 20 most recent papers
Pediatric Neurology

Bortezomib-Responsive Refractory Anti-N-Methyl-d-Aspartate Receptor Encephalitis

Pediatric NeurologyNovember 25, 2019
Ramona CordaniMaria Margherita Mancardi
1
Neurology. Neuroimmunology and Neuroinflammation

Clinical significance of Kelch-like protein 11 antibodies

Neurology. Neuroimmunology and NeuroinflammationJanuary 19, 2020
Estibaliz MaudesLidia Sabater
4
Annals of Neurology

Human Cerebrospinal Fluid Monoclonal LGI1 Autoantibodies Increase Neuronal Excitability

Annals of NeurologyJanuary 5, 2020
Hans-Christian KornauDietmar Schmitz
3
Neurology. Neuroimmunology and Neuroinflammation

Pediatric autoimmune encephalitis: Recognition and diagnosis

Neurology. Neuroimmunology and NeuroinflammationFebruary 13, 2020
Marienke A A M de BruijnCHANCE Study Group
25
1
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies

Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study

European Journal of Neurology : the Official Journal of the European Federation of Neurological SocietiesDecember 10, 2019
M GastaldiD Franciotta
13
Auto- Immunity Highlights

Receptor autoimmunity: diagnostic and therapeutic implications

Auto- Immunity HighlightsMarch 5, 2020
Renato Tozzoli
Nederlands tijdschrift voor geneeskunde

Acute neuropsychiatry: a confused patient and a puzzled doctor

Nederlands tijdschrift voor geneeskundeFebruary 20, 2020
Hester EppingaWilleke H van Zelst
Frontiers in Neurology

Serum Systemic Autoantibodies in Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Frontiers in NeurologyMarch 18, 2020
Bingjun ZhangZhengqi Lu
Case Reports in Neurology

Headache, Delirium or Encephalitis? A Case of Residual Mutism Secondary to Anti-NMDA Receptor Encephalitis

Case Reports in NeurologyJanuary 9, 2020
Omar Jiménez-ZarazúaJaime D Mondragón
BMC Infectious Diseases

Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis

BMC Infectious DiseasesJanuary 9, 2020
Maria StavrouPeter Foley
3
Frontiers in Neurology

In vivo Mechanisms of Antibody-Mediated Neurological Disorders: Animal Models and Potential Implications

Frontiers in NeurologyMarch 3, 2020
Maria Pia GiannoccaroAngela Vincent
Journal of Neurology

Possible N-methyl-D-aspartate receptor antibody-mediated encephalitis in the setting of HIV cerebrospinal fluid escape

Journal of NeurologyJanuary 22, 2020
Patrick B MoloneyAnna M Cervantes-Arslanian

See more papers from this feed

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

© 2020 Meta ULC. All rights reserved
/feed-previews/anti-n-methyl-d-aspartate-receptor/0517bf9b-8746-4527-b692-f65251b4564b